The S&P 500 soared more than 32% in 2013, and several big pharma companies, namely Bristol-Myers Squibb (BMY 4.05%), AbbVie (ABBV +0.03%), Roche (RHHBY 1.25%), Johnson & Johnson (JNJ +0.35%), and AstraZeneca (AZN +0.55%) also performed extraordinarily well. The following slideshow reveals why these companies beat out their big pharma peers and what drove their strong performances in 2013.
The pharmaceutical sector had a stellar 2013, but which stocks were the best?
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo